PDCD1 and hepatocellular carcinoma: To assess the efficacy of anti‐PD‐1 treatment alone or combined with anlotinib in vitro, we used a 3D microfluidic device (AIM Biotech, DAX‐1 idenTx 3 Chip) to develop a short‐term culture of HCC PDOTs.17, 18